Ushering in the Golden Era of Alzheimer Drug Development?

RJ Tesi, MD

Dr Tesi is CEO and Chief Medical Officer of INmuneBio.

What effect will aducanumab have on Alzheimer disease treatment?

RJ Tesi, MD, discusses the recent aducanumab FDA approval and the implications it will have on the treatment of Alzheimer disease.

Dr Tesi is CEO and Chief Medical Officer of INmuneBio.